Vigil Neuroscience TREM2 Agonists ATP Transporter 1 Patent EP4255567A1
Summary
The European Patent Office published patent application EP4255567A1 for Vigil Neuroscience, Inc., covering TREM2 agonists for the treatment of diseases related to ATP-binding cassette transporter 1 dysfunction. The patent names inventors Papapetropoulos, Fisher, and Brennan, with applications extending to neurological conditions including Alzheimer's and Parkinson's diseases. The patent designates 35 Contracting States for protection.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO published patent application EP4255567A1 for Vigil Neuroscience, Inc., covering TREM2 agonist compositions and methods of treating diseases related to ATP-binding cassette transporter 1 dysfunction. The patent application, with inventors Papapetropoulos, Fisher, and Brennan, includes multiple IPC classifications covering neurological applications such as Alzheimer's and Parkinson's diseases, as well as metabolic conditions.\n\nThis patent publication affects biotechnology and pharmaceutical companies engaged in TREM2-targeted therapeutic development or ATP-binding cassette transporter research. Companies operating in this space should review their R&D programs for potential licensing needs or freedom-to-operate analysis regarding TREM2 agonist technologies.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS
Publication EP4255567A1 Kind: A1 Apr 15, 2026
Applicants
Vigil Neuroscience, Inc.
Inventors
PAPAPETROPOULOS, Spyridon, FISHER, Richard, BRENNAN, Matthew
IPC Classifications
A61P 25/00 20060101AFI20241011BHEP A61P 25/14 20060101ALI20241011BHEP A61P 25/28 20060101ALI20241011BHEP A61K 48/00 20060101ALI20241011BHEP C07K 14/705 20060101ALI20241011BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.